Jade Biosciences Inc. (JBIO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Jade Biosciences Inc.

    NASDAQ: JBIO · Real-Time Price · USD
    8.86
    0.53 (6.36%)
    At close: Oct 03, 2025, 3:59 PM
    8.35
    -5.76%
    After-hours: Oct 03, 2025, 05:57 PM EDT

    Jade Biosciences Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -93.96K -75.52M -51.51M -22.96M
    Depreciation & Amortization
    		 n/a 96K 68K 15K
    Stock-Based Compensation
    		 2.51K n/a n/a n/a
    Other Working Capital
    		 -9M 9.96M 6.39M -7.12M
    Other Non-Cash Items
    		 -59.94M 8.85M 4.57M 2.06M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -11.17M 9.8M 7.75M -6.51M
    Operating Cash Flow
    		 -71.2M -56.78M -39.12M -27.4M
    Capital Expenditures
    		 n/a -142K -195K -181K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -19.68M -123.98M -147.62M -113.25M
    Sales Maturities Of Investments
    		 75.71M 136M 154.74M n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 56.03M 11.88M 6.93M -113.43M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a n/a
    Financial Cash Flow
    		 25.43M 46M 396K 190.46M
    Net Cash Flow
    		 10.26M 1.09M -31.8M 49.62M
    Free Cash Flow
    		 -45.23K -56.92M -39.32M -27.58M

    Add to Watchlist